OBJECTIVE: To evaluate long-term device outcomes following primary artificial urinary sphincter (AUS) implantation. MATERIALS AND METHODS: We identified 1802 male patients with stress urinary incontinence that underwent AUS placement from 1983 to 2011. Of these, 1082 (60%) were involving primary implantations and comprise the study cohort. Multiple clinical and surgical variables were evaluated for potential association with treatment failure, defined as any secondary surgery. Patient follow-up was obtained through office examination, operative report, and written or telephone correspondence. RESULTS: Patients undergoing AUS implantation had a median age of 71 years (interquartile range 66-76) and median follow-up of 4.1 years (interquartile range 0.8-7.7). Overall, 338 of 1082 patients (31.2%) underwent secondary surgery, including 89 for device infection and/or erosion, 131 for device malfunction, 89 for urethral atrophy, and 29 for pump malposition or tubing complications. No patient-related risk factors were independently associated with an increased risk of secondary surgery on multivariable analysis. Secondary surgery-free survival was 90% at 1 year, 74% at 5 years, 57% at 10 years, and 41% at 15 years. CONCLUSION: Primary AUS implantation is associated with acceptable long-term outcomes. Recognition of long-term success is important for preoperative patient counseling.
OBJECTIVE: To evaluate long-term device outcomes following primary artificial urinary sphincter (AUS) implantation. MATERIALS AND METHODS: We identified 1802 male patients with stress urinary incontinence that underwent AUS placement from 1983 to 2011. Of these, 1082 (60%) were involving primary implantations and comprise the study cohort. Multiple clinical and surgical variables were evaluated for potential association with treatment failure, defined as any secondary surgery. Patient follow-up was obtained through office examination, operative report, and written or telephone correspondence. RESULTS:Patients undergoing AUS implantation had a median age of 71 years (interquartile range 66-76) and median follow-up of 4.1 years (interquartile range 0.8-7.7). Overall, 338 of 1082 patients (31.2%) underwent secondary surgery, including 89 for device infection and/or erosion, 131 for device malfunction, 89 for urethral atrophy, and 29 for pump malposition or tubing complications. No patient-related risk factors were independently associated with an increased risk of secondary surgery on multivariable analysis. Secondary surgery-free survival was 90% at 1 year, 74% at 5 years, 57% at 10 years, and 41% at 15 years. CONCLUSION: Primary AUS implantation is associated with acceptable long-term outcomes. Recognition of long-term success is important for preoperative patient counseling.
Authors: Matthew J Ziegelmann; Brian J Linder; Marcelino E Rivera; Boyd R Viers; Daniel S Elliott Journal: Can Urol Assoc J Date: 2016 Nov-Dec Impact factor: 1.862
Authors: Sandra Mühlstädt; Alexander Friedl; Nasreldin Mohammed; André Schumann; Karl Weigand; Felix Kawan; Christian Göllert; Christin Kahlert; Gerit Theil; Kersten Fischer; Paolo Fornara Journal: World J Urol Date: 2016-05-07 Impact factor: 4.226
Authors: Roger K Khouri; Nicolas M Ortiz; Benjamin M Dropkin; Gregory A Joice; Adam S Baumgarten; Allen F Morey; Steven J Hudak Journal: Curr Urol Rep Date: 2021-03-29 Impact factor: 3.092
Authors: Carlos Alberto Ricetto Sacomani; Stênio de Cássio Zequi; Walter Henriques da Costa; Bruno Santos Benigno; Rodrigo Sousa Madeira Campos; Wilson Bachega; Gustavo Cardoso Guimarães Journal: Int Braz J Urol Date: 2018 Jan-Feb Impact factor: 1.541
Authors: Matthew J Ziegelmann; Brian J Linder; Boyd R Viers; Laureano J Rangel; Marcelino E Rivera; Daniel S Elliott Journal: Turk J Urol Date: 2018-11-26
Authors: Melanie A Adamsky; William R Boysen; Andrew J Cohen; Sandra Ham; Roger R Dmochowski; Sarah F Faris; Gregory T Bales; Joshua A Cohn Journal: Urology Date: 2017-09-28 Impact factor: 2.649